Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think
- PMID: 21948802
- PMCID: PMC3182047
- DOI: 10.1084/jem.20111855
Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think
Abstract
Notch signaling is often considered a model hematopoietic proto-oncogene because of its role as the main trigger of T cell acute lymphoblastic leukemia (T-ALL). Although its role in T-ALL is well characterized and further supported by a high frequency of activating NOTCH1 mutations in T-ALL patients, it still remains an open question whether the effects of Notch signaling are causative in other types of cancer, including solid tumors. Growing evidence supported by recent studies unexpectedly shows that Notch signaling can also have a potent tumor suppressor function in both solid tumors and hematological malignancies. We discuss the intriguing possibility that the pleiotropic functions of Notch can be tumor suppressive or oncogenic depending on the cellular context.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA173636/CA/NCI NIH HHS/United States
- R01 CA133379/CA/NCI NIH HHS/United States
- R01CA133379/CA/NCI NIH HHS/United States
- R21CA141399/CA/NCI NIH HHS/United States
- R01 CA149655/CA/NCI NIH HHS/United States
- R01 CA105129/CA/NCI NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- R21 CA141399/CA/NCI NIH HHS/United States
- R01CA149655/CA/NCI NIH HHS/United States
- R01CA105129/CA/NCI NIH HHS/United States
- R01 GM088847/GM/NIGMS NIH HHS/United States
- R01GM088847/GM/NIGMS NIH HHS/United States
- R01 CA169784/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical